Avaliação de massa mamária
Resumo
Diagnósticos diferenciais
comuns
- Fibroadenoma
- Mama fibrocística
- Necrose gordurosa
- Papiloma intraductal
- Abscesso mamário
- Câncer de mama invasivo
- Carcinoma ductal in situ (CDIS)
Incomuns
- Tumor filoide
- Adenoma
- Hiperplasia ductal atípica (HDA) e hiperplasia lobular atípica (HLA)
- Cicatriz radial
- Carcinoma lobular in situ (CLIS)
Colaboradores
Autores
Marios-Konstantinos Tasoulis, MD, PhD
Consultant Breast Surgeon
Breast Surgery Unit
The Royal Marsden Hospital NHS Foundation Trust
London
UK
Declarações
M-KT declares that he has no competing interests.
Agradecimentos
Dr Marios-Konstantinos Tasoulis would like to gratefully acknowledge Professor Anees Chagpar and Dr Matthew Bower, previous contributors to this topic. AC and MB declare that they have no competing interests.
Revisores
William Dooley, MD, FACS
Director of Surgical Oncology
Department of Surgery
University of Oklahoma
G. Rainey Williams Chair in Surgical Breast Oncology
OU Breast Institute
Oklahoma City
OK
Declarações
WD declares that he has no competing interests.
Jesus Solier Insuasty Enriquez, MD
Oncology Unit
Hospital Universitario Ramon Gonzalez Valencia
Bucaramanga
Colombia
Declarações
JE declares that he has no competing interests.
Justin Stebbing, MA, MRCP, MRCPath, PhD
Consultant Medical Oncologist/Senior Lecturer
Department of Medical Oncology
Imperial College/Imperial Healthcare NHS Trust
Charing Cross Hospital
London
UK
Declarações
JS declares that he has no competing interests.
Diretrizes
- NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis
- Suspected cancer: recognition and referral
DiretrizesFolhetos informativos para os pacientes
Câncer de mama: CDIS (câncer de mama em estágio muito inicial) em mulheres
Câncer de mama localmente avançado: o que é?
Mais Folhetos informativos para os pacientes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal